CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
1.090
-0.010 (-0.91%)
At close: Dec 20, 2024, 4:00 PM
1.067
-0.023 (-2.11%)
After-hours: Dec 20, 2024, 6:50 PM EST
CytomX Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | 13.83 | -0.57 | -99.32 | -115.87 | -64.82 | -132.83 | |
| Depreciation & Amortization | 1.84 | 2.18 | 2.44 | 2.71 | 2.57 | 2.61 | |
| Asset Writedown & Restructuring Costs | - | - | 0.25 | - | - | - | |
| Loss (Gain) From Sale of Investments | -6.75 | -7.42 | -0.05 | 0.27 | -0.24 | -2.23 | |
| Stock-Based Compensation | 8.34 | 8.56 | 13.13 | 13.17 | 14.79 | 19.1 | |
| Other Operating Activities | 3.99 | 3.73 | 3.41 | 3.13 | 2.89 | 4.27 | |
| Change in Accounts Receivable | -0.93 | 32.55 | -35.2 | 0.01 | -0.79 | 0.08 | |
| Change in Accounts Payable | -0.36 | -1.43 | 0.07 | -0.14 | -0.86 | -0.37 | |
| Change in Unearned Revenue | -107.04 | -89.01 | 16.57 | -33.95 | 62.83 | -17.15 | |
| Change in Other Net Operating Assets | -1.2 | -4.63 | -12.09 | 11.64 | -11.12 | -13.96 | |
| Operating Cash Flow | -88.29 | -56.04 | -110.79 | -119.03 | 5.26 | -140.48 | |
| Capital Expenditures | -0.5 | -0.84 | -1.74 | -1.61 | -2.31 | -3.5 | |
| Investment in Securities | 97.93 | -149.83 | 100 | 24.1 | -16.41 | 83.2 | |
| Investing Cash Flow | 97.43 | -150.67 | 98.26 | 22.49 | -18.72 | 79.7 | |
| Issuance of Common Stock | 5.52 | 0.56 | 0.65 | 110.21 | 16.89 | 1.63 | |
| Other Financing Activities | - | 29.67 | - | - | - | - | |
| Financing Cash Flow | 5.52 | 30.23 | 0.65 | 110.21 | 16.89 | 1.63 | |
| Net Cash Flow | 14.66 | -176.48 | -11.88 | 13.67 | 3.43 | -59.15 | |
| Free Cash Flow | -88.78 | -56.88 | -112.53 | -120.64 | 2.95 | -143.98 | |
| Free Cash Flow Margin | -70.12% | -56.19% | -211.67% | -323.33% | 4.31% | -535.19% | |
| Free Cash Flow Per Share | -1.06 | -0.77 | -1.71 | -1.88 | 0.06 | -3.18 | |
| Cash Income Tax Paid | - | - | - | - | - | 13.06 | |
| Levered Free Cash Flow | -13.73 | 43.66 | -8.92 | -46.11 | -53.86 | -83.19 | |
| Unlevered Free Cash Flow | -13.73 | 43.66 | -8.92 | -46.11 | -53.86 | -83.19 | |
| Change in Net Working Capital | 27.6 | -37.82 | -35.9 | -12.16 | 18.57 | 12.97 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.